Apply BAU Apply BAU Apply BAU

BAU Launches the Center for Computational Drug Design (HİTMER)

BAU Launches the Center for Computational Drug Design (HİTMER)

The Bahçeşehir University (BAU) Computational Drug Design Center (HİTMER), where drug design and development stages will be carried out with artificial intelligence, has opened.

Established to increase pharmaceutical R&D activities in Türkiye and to have a voice in this field at the international level, the Bahçeşehir University (BAU) Computational Drug Design Center (HİTMER) has opened. At HİTMER, which will carry out all stages of drug design and development against diseases with artificial intelligence, students working in the field will also specialize.

BAU’nun ilaç tasarım merkezi açıldı

The opening ceremony of HİTMER, established at the BAU Göztepe Campus, was attended by BAU President Prof. Dr. Esra Hatipoğlu, BAU Faculty of Pharmacy Dean and HİTMER Director Prof. Dr. Serdar Durdağı, Head of the Department of Medical Biology at the BAU Faculty of Medicine Assoc. Prof. Dr. Timuçin Avşar, faculty members and students.

BAU Faculty of Pharmacy Dean and HİTMER Director Prof. Dr. Serdar Durdağı said: "Today we are opening the Computational Drug Design Center, HİTMER for short, within Bahçeşehir University. What will be done at the Computational Drug Design Center? It is a center with an artificial intelligence theme, an area that has already been developing at our university in recent years. At this center, we plan to develop new drugs, new drugs for the diseases of the future, using in particular the very broad approaches and tools of artificial intelligence. Our whole aim is to help work progress much faster, especially with artificial intelligence, and to develop medicines that will bring healing to patients at this center."

BAU’nun ilaç tasarım merkezi açıldı

"There Is No Other Example in Türkiye"

Prof. Dr. Serdar Durdağı said: "There is no other example of this center; we are doing it for the first time. In Türkiye, it was opened with the support of the Istanbul Development Agency in particular and with the support of our university. We received support to establish this center in 2021 and we are now opening it. There are similar laboratories in our country, but this is the first time a center has been formed as an artificial intelligence-themed drug development center. At our center, master's, doctoral and postdoctoral students in particular work as specialists and assistant specialists. It has been planned and designed to allow 20 researchers to work at the same time in an area of approximately 300 square meters, especially in the field where artificial intelligence will be used. In total, we will have trained around 40 of our students at this center."

BAU’nun ilaç tasarım merkezi açıldı